Efficacy News and Research

RSS

Deep brain stimulation effective in resistant depression

A new study in the American Journal of Psychiatry says deep brain stimulation is an effective treatment in depressed patients who do not respond to other forms of therapy. The study published on October 4, 2019, looked at the long-term effects on patients who had received electrical stimulation to the subcallosal cingulate area of the brain. The subcallosal cingulate area of the brain is also called Brodmann Area 25, and has been targeted by researchers as a possible focus for antidepressant stimulation.

7 Oct 2019

Henry Ford West Bloomfield Hospital earns Thrombectomy-Capable Stroke Center certification

Henry Ford West Bloomfield Hospital is one of only two Michigan hospitals to earn a Thrombectomy-Capable Stroke Center certification from The Joint Commission, an independent, not-for-profit organization that accredits and certifies more than 22,000 healthcare organizations and programs in the United States.

4 Oct 2019

Antibody that targets CXCR6 prevents and reverses multiple sclerosis in mouse model

Multiple sclerosis, an autoimmune disorder, is known to be driven by "helper" T cells, white blood cells that mount an inflammatory attack on the brain and spinal cord. A new study from Boston Children's Hospital pinpoints the specific subgroup of helper T cells that cause MS, as well as a protein on their surface, called CXCR6, that marks them.

4 Oct 2019

Phage engineering gives antibacterial therapy a new lease of life

Researchers have been identifying and modifying known phages to fight against infectious bacteria.

4 Oct 2019

Research supports role of efficacy-first natural regimens to restore and improve skin health

Burt's Bees, a pioneer in natural skin care, today announced research supporting the role of efficacy-first natural regimens to defend, restore and improve skin health.

4 Oct 2019

Long-term study data shows DBS is effective for patients with treatment-resistant depression

A study published online on Friday, October 4, in the American Journal of Psychiatry found that deep brain stimulation (DBS) of an area in the brain called the subcallosal cingulate (SCC) provides a robust antidepressant effect that is sustained over a long period of time in patients with treatment-resistant depression--the most severely depressed patients who have not responded to other treatments.

4 Oct 2019

Clinical trial explores effect of whole-body cooling in comatose patients after cardiac arrest

While body temperature cooling is not a new treatment tactic for patients who experience cardiac arrest, a new clinical trial hopes to better understand the optimal amount of time for targeted temperature management.

4 Oct 2019

Researchers are developing new therapy to counter the effects of traumatic brain injury

A blow to the head or powerful shock wave on the battlefield can cause immediate, significant damage to a person's skull and the tissue beneath it.

4 Oct 2019

Study may help in personalizing treatment for lung cancer, develop new drugs

Researchers at the University of Copenhagen have used highly sophisticated molecular analyses to identify key proteins in the signaling pathways that cancers use to spread in the body.

4 Oct 2019

Reporting skill and concussion symptom knowledge increase concussion reporting

Concussions often are underreported by those experiencing symptoms, and most education programs assume that increased knowledge will improve that rate. But new research from the University of Georgia suggests that knowing how to report a concussion - rather than knowing more about concussions - is a greater factor in prompting athletes to take action.

3 Oct 2019

Connected diabetes care can become part of a new diabetes care model

Digital diabetes management systems ("connected diabetes care") have the potential to become part of a new diabetes care model, augmenting the traditional practice of diabetes care by providing continuous and on-demand assistance that aligns with the 24/7 demands of diabetes as a chronic disease.

3 Oct 2019

Common gout medications can kill elephantiasis-causing parasites

Treatment with two common FDA-approved gout medications have been found to cause rapid death to the parasites that cause elephantiasis.

3 Oct 2019

Innovative compound kills cancer cells, minimizes damage to normal tissues

Most of the current clinical anti-tumor drugs used in chemotherapy move around in the patient's blood after intake and are unable to pinpoint the targeted tumor. As a result, while killing the tumor cells, the healthy cells may also be killed as "collateral damage", leading to undesired side effects.

3 Oct 2019

High-resolution imaging shows how HIV spreads between living cells

In order to treat diseases better, we must understand how they arise.

3 Oct 2019

New mechanism that controls DNA repair identified

Deoxyribonucleic acid (DNA), is the macromolecule that holds all hereditary and genetic information. Continuously under assault, alterations and damage to DNA can lead to many different health issues, including cancer.

2 Oct 2019

Laser therapy can be safe and effective in treating vaginal problems, study suggests

Nearly 50% of menopausal women complain of vaginal dryness, itching, and burning, among other commonly reported menopause symptoms. Laser therapy is one of the newer techniques for addressing these problems.

2 Oct 2019

Researchers find no evidence of adverse health outcomes linked with antidepressant use

Antidepressants are generally safe, according to a new study by an international team of researchers. By assessing evidence from 45 meta-analyses, which combined the results from many studies, the researchers did not find strong evidence of adverse health outcomes associated with antidepressant use.

2 Oct 2019

CAR T-cell therapy may be effective in killing solid tumor cells

There is now a multitude of therapies to treat cancer, from chemotherapy and radiation to immunotherapy and small molecule inhibitors. Chemotherapy is still the most widely used cancer treatment, but chemotherapy attacks all the rapidly dividing cells that it locates within the body, whether they're ultimately harmful or beneficial.

2 Oct 2019

New study shows response to HIV vaccine in 6 weeks

A US study on DNA-based and protein HIV vaccines has shown that an antibody and cellular immune response occurs within six weeks.

2 Oct 2019

New study shows response to HIV vaccine in 6 weeks

A new study using DNA-based and protein HIV vaccines in various combinations shows that antibody and cellular immune response occurs within 6 weeks from the date of vaccination, and the combination must be administered together for the most rapid protection. This will enable more large-scale testing of the vaccine for effectiveness. About 40 million people today have HIV infections, and 1.2 million deaths a year are related to this infection.

1 Oct 2019

Efficacy News and Research

Deep brain stimulation effective in resistant depression

Henry Ford West Bloomfield Hospital earns Thrombectomy-Capable Stroke Center certification

Antibody that targets CXCR6 prevents and reverses multiple sclerosis in mouse model

Phage engineering gives antibacterial therapy a new lease of life

Research supports role of efficacy-first natural regimens to restore and improve skin health

Long-term study data shows DBS is effective for patients with treatment-resistant depression

Clinical trial explores effect of whole-body cooling in comatose patients after cardiac arrest

Researchers are developing new therapy to counter the effects of traumatic brain injury

Study may help in personalizing treatment for lung cancer, develop new drugs

Reporting skill and concussion symptom knowledge increase concussion reporting

Connected diabetes care can become part of a new diabetes care model

Common gout medications can kill elephantiasis-causing parasites

Innovative compound kills cancer cells, minimizes damage to normal tissues

High-resolution imaging shows how HIV spreads between living cells

New mechanism that controls DNA repair identified

Laser therapy can be safe and effective in treating vaginal problems, study suggests

Researchers find no evidence of adverse health outcomes linked with antidepressant use

CAR T-cell therapy may be effective in killing solid tumor cells

New study shows response to HIV vaccine in 6 weeks

New study shows response to HIV vaccine in 6 weeks

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News